Simple Scoring System for Esophagogastric Varices Prediction in Hepatocellular Carcinoma Patients without Liver Stiffness Evaluation
Oncology · 2024 · 102 (4) · 291-298
DOI: 10.1159/000533672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, online erschienen am 11.10.2023. Verfasst von Atsushi Hiraoka und 22 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Esophageal and Gastric Varices, Varicose Veins. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
For predicting esophagogastric varices (EGVs), the Virtual Baveno VII Consensus Workshop has proposed a combination of liver stiffness determination and platelet count measurement using a FibroScan®. However, FibroScan® is not available at all institutions. The present study aimed to develop a simple method to predict development of EGV using only general blood examination results. Materials and Methods: A total of 1,090 hepatocellular carcinoma patients were enrolled, after excluding 956 with major portal vein tumor thrombus (Vp3/Vp4) or without upper gastrointestinal endoscopy examination results available. Those with EGV (≥ grade F2) or a history of treatment for the condition were defined as positive for significant EGV, and then clinical factors were retrospectively evaluated to determine indicators of occurrence.
Results
Logistic multivariate analysis showed platelet count (≤12 × 104/μL) (odds ratio [OR] 3.79, p < 0.001), mALBI grade 2a (OR 1.52, p = 0.036), and mALBI 2b or 3 (OR 3.46, p < 0.001) as significant predictive factors. Based on the OR values, platelet count (≤12 × 104/μL) and mALBI grade 2b/3 were each assigned 2 points and mALBI 2a was given 1 point, with the result termed recommendation for EGV screening (REGS) score. Significant EGV occurrence was noted in 2.9% (9/311) of the patients with a REGS score 0, 11.0% (13/118) with a score 1, 19.3% (53/274) with a score 2, 29.5% (39/132) with a score 3, and 38.0% (97/255) with a score 4 (p < 0.001).
Conclusion
The findings indicate that REGS score can provide useful predictive information for development of significant EGV without the need for special equipment such as a FibroScan®.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.
- Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Japan.
Zitieren
APA
Hiraoka, A., Tada, F., Ohama, H., Fukumoto, M., Matsuoka, K., Matsuda, T., Nakatani, K., Yanagihara, E., Saneto, H., Izumoto, H., Murakami, T., Onishi, K., Kitahata, S., Kanemitsu-Okada, K., Kawamura, T., Kuroda, T., Miyata, H., Tsubouchi, E., Hirooka, M., …, & Hiasa, Y. (2024). Simple Scoring System for Esophagogastric Varices Prediction in Hepatocellular Carcinoma Patients without Liver Stiffness Evaluation. Oncology, 102(4), 291-298. https://doi.org/10.1159/000533672
Vancouver
Hiraoka A, Tada F, Ohama H, Fukumoto M, Matsuoka K, Matsuda T, et al. Simple Scoring System for Esophagogastric Varices Prediction in Hepatocellular Carcinoma Patients without Liver Stiffness Evaluation. Oncology. 2024;102(4):291-298. doi:10.1159/000533672
BibTeX
@article{Hiraoka2024,
author = {Hiraoka, Atsushi and Tada, Fujimasa and Ohama, Hideko and Fukumoto, Mai and Matsuoka, Kana and Matsuda, Takuya and Nakatani, Kosuke and Yanagihara, Emi and Saneto, Hironobu and Izumoto, Hirofumi and Murakami, Taisei and Onishi, Kei and Kitahata, Shogo and Kanemitsu-Okada, Kozue and Kawamura, Tomoe and Kuroda, Taira and Miyata, Hideki and Tsubouchi, Eiji and Hirooka, Masashi and Abe, Masanori and Matsuura, Bunzo and Ninomiya, Tomoyuki and Hiasa, Yoichi},
title = {Simple Scoring System for Esophagogastric Varices Prediction in Hepatocellular Carcinoma Patients without Liver Stiffness Evaluation},
journal = {Oncology},
year = {2024},
volume = {102},
number = {4},
pages = {291--298},
doi = {10.1159/000533672}
}
EUVIMED